|
Details |
| Establishment |
1956,
An autonomous body under the Ministry of Health and Family Welfare |
| Primary Objective |
To promote public health by setting and updating standards for drug quality in India. |
| Key Publication |
Indian Pharmacopoeia (IP), a legally recognized book of drug standards. |
| Role in Drug Regulation |
Standards set in the IP are enforceable by law, crucial for India’s drug regulatory framework. |
| International Recognition |
Collaborates with WHO and aligns with global drug standards. |
| Pharmacovigilance Program |
Involved in monitoring and analyzing adverse drug reactions through the PvPI. |
| Quality Control & Training |
Engages in drug quality control and provides training to regulatory bodies and the pharmaceutical industry. |
| Publication Updates |
Periodically updates the IP to include new drugs and revise existing standards. |
| Collaboration |
Works with the pharmaceutical industry, academia, and regulatory bodies. |
| Global Harmonization |
Aims to harmonize the IP with international pharmacopoeias like the USP and BP. |